These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

196 related items for PubMed ID: 9608317

  • 1. Update on immunosuppressive therapy.
    Singer NG, McCune WJ.
    Curr Opin Rheumatol; 1998 May; 10(3):169-73. PubMed ID: 9608317
    [Abstract] [Full Text] [Related]

  • 2. Cytotoxic drugs: their clinical application to the rheumatic diseases.
    Clements PJ, Davis J.
    Semin Arthritis Rheum; 1986 May; 15(4):231-54. PubMed ID: 2872726
    [No Abstract] [Full Text] [Related]

  • 3. The dynamism of cutaneous lupus erythematosus: mild discoid lupus erythematosus evolving into SLE with SCLE and treatment-resistant lupus panniculitis.
    Wozniacka A, Salamon M, Lesiak A, McCauliffe DP, Sysa-Jedrzejowska A.
    Clin Rheumatol; 2007 Jul; 26(7):1176-9. PubMed ID: 16645776
    [Abstract] [Full Text] [Related]

  • 4. Immunosuppressive therapy in rheumatic disease.
    Pirofsky B, Bardana EJ.
    Med Clin North Am; 1977 Mar; 61(2):419-37. PubMed ID: 16187
    [No Abstract] [Full Text] [Related]

  • 5. Immunosuppressive medication use and risk of herpes zoster (HZ) in patients with systemic lupus erythematosus (SLE): A nationwide case-control study.
    Hu SC, Yen FL, Wang TN, Lin YC, Lin CL, Chen GS.
    J Am Acad Dermatol; 2016 Jul; 75(1):49-58. PubMed ID: 26946984
    [Abstract] [Full Text] [Related]

  • 6. Immunosuppressive drug use in pregnancy.
    Petri M.
    Autoimmunity; 2003 Feb; 36(1):51-6. PubMed ID: 12765471
    [Abstract] [Full Text] [Related]

  • 7. Immunosuppressive drug therapy of systemic lupus erythematosus.
    Fox DA, McCune WJ.
    Rheum Dis Clin North Am; 1994 Feb; 20(1):265-99. PubMed ID: 8153402
    [Abstract] [Full Text] [Related]

  • 8. Mechanisms of action and clinical applications of cytotoxic drugs in rheumatic disorders.
    Nashel DJ.
    Med Clin North Am; 1985 Jul; 69(4):817-40. PubMed ID: 3903379
    [Abstract] [Full Text] [Related]

  • 9. Therapy-related myelodysplastic syndrome following cyclophosphamide pulse and/or methotrexate therapy in a patient with systemic lupus erythematosus.
    Iwadate H, Kobayashi H, Yano K, Watanabe H, Ikeda K, Ogawa K, Ohira H.
    Fukushima J Med Sci; 2010 Dec; 56(2):121-7. PubMed ID: 21502712
    [Abstract] [Full Text] [Related]

  • 10. Immunosuppressive drug therapy.
    McCune WJ, Vallance DK, Lynch JP.
    Curr Opin Rheumatol; 1994 May; 6(3):262-72. PubMed ID: 8060760
    [Abstract] [Full Text] [Related]

  • 11. Acute nonlymphocytic leukemia after treatment of systemic lupus erythematosus with immunosuppressive agents.
    Vasquez S, Kavanaugh AF, Schneider NR, Wacholtz MC, Lipsky PE.
    J Rheumatol; 1992 Oct; 19(10):1625-7. PubMed ID: 1464880
    [Abstract] [Full Text] [Related]

  • 12. Cyclosporine and therapeutic plasma exchange in treatment of progressive autoimmune diseases.
    Schiel R, Bambauer R, Latza R, Klinkmann J.
    Artif Organs; 1997 Sep; 21(9):983-8. PubMed ID: 9288868
    [Abstract] [Full Text] [Related]

  • 13. EULAR recommendations for the management of systemic lupus erythematosus: 2023 update.
    Fanouriakis A, Kostopoulou M, Andersen J, Aringer M, Arnaud L, Bae SC, Boletis J, Bruce IN, Cervera R, Doria A, Dörner T, Furie RA, Gladman DD, Houssiau FA, Inês LS, Jayne D, Kouloumas M, Kovács L, Mok CC, Morand EF, Moroni G, Mosca M, Mucke J, Mukhtyar CB, Nagy G, Navarra S, Parodis I, Pego-Reigosa JM, Petri M, Pons-Estel BA, Schneider M, Smolen JS, Svenungsson E, Tanaka Y, Tektonidou MG, Teng YO, Tincani A, Vital EM, van Vollenhoven RF, Wincup C, Bertsias G, Boumpas DT.
    Ann Rheum Dis; 2024 Jan 02; 83(1):15-29. PubMed ID: 37827694
    [Abstract] [Full Text] [Related]

  • 14. Ocular cicatricial pemphigoid.
    Tauber J.
    Ophthalmology; 2008 Sep 02; 115(9):1639-40; author reply 1640-1. PubMed ID: 18762085
    [No Abstract] [Full Text] [Related]

  • 15. [Wegener's granulomatosis (morbus Wegener)].
    Kolyvanos Naumann U, Käser L, Vetter W.
    Praxis (Bern 1994); 2003 Nov 12; 92(46):1943-7. PubMed ID: 14765551
    [No Abstract] [Full Text] [Related]

  • 16. Azathioprine or methotrexate maintenance for ANCA-associated vasculitis.
    Pagnoux C, Mahr A, Hamidou MA, Boffa JJ, Ruivard M, Ducroix JP, Kyndt X, Lifermann F, Papo T, Lambert M, Le Noach J, Khellaf M, Merrien D, Puéchal X, Vinzio S, Cohen P, Mouthon L, Cordier JF, Guillevin L, French Vasculitis Study Group.
    N Engl J Med; 2008 Dec 25; 359(26):2790-803. PubMed ID: 19109574
    [Abstract] [Full Text] [Related]

  • 17. [Recommendations for immunosuppressive therapy in systemic lupus erythematosus].
    Deicher H.
    Monatsschr Kinderheilkd (1902); 1972 Jun 25; 120(6):249-51. PubMed ID: 4115641
    [No Abstract] [Full Text] [Related]

  • 18. Drug therapy: immunosuppressive agents (second of two parts).
    Kaplan SR, Calabresi P.
    N Engl J Med; 1973 Dec 06; 289(23):1234-6. PubMed ID: 4594161
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.